These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 16846722)

  • 1. Liquid boundary movements in cylindrical and convex hydrophobic matrix tablets: Effects on tablet cracking and drug release.
    Pajander J; van Veen B; Korhonen O; Lappalainen R; Ketolainen J
    Eur J Pharm Biopharm; 2006 Oct; 64(2):167-72. PubMed ID: 16846722
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effect of powder blend and tablet structure on drug release mechanisms of hydrophobic starch acetate matrix tablets.
    van Veen B; Pajander J; Zuurman K; Lappalainen R; Poso A; Frijlink HW; Ketolainen J
    Eur J Pharm Biopharm; 2005 Oct; 61(3):149-57. PubMed ID: 16005196
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Drug release phenomena within a hydrophobic starch acetate matrix: FTIR mapping of tablets after in vitro dissolution testing.
    Pajander J; Soikkeli AM; Korhonen O; Forbes RT; Ketolainen J
    J Pharm Sci; 2008 Aug; 97(8):3367-78. PubMed ID: 18085712
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vitro and in vivo sustained-release characteristics of theophylline matrix tablets and novel cluster tablets.
    Hayashi T; Kanbe H; Okada M; Kawase I; Ikeda Y; Onuki Y; Kaneko T; Sonobe T
    Int J Pharm; 2007 Aug; 341(1-2):105-13. PubMed ID: 17512147
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Modulation of drug release kinetics from hydroxypropyl methyl cellulose matrix tablets using polyvinyl pyrrolidone.
    Hardy IJ; Windberg-Baarup A; Neri C; Byway PV; Booth SW; Fitzpatrick S
    Int J Pharm; 2007 Jun; 337(1-2):246-53. PubMed ID: 17306477
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Drug release behaviour from methyl methacrylate-starch matrix tablets: effect of polymer moisture content.
    Bravo-Osuna I; Ferrero C; Jiménez-Castellanos MR
    Eur J Pharm Biopharm; 2008 May; 69(1):285-93. PubMed ID: 17997292
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A study of tablet dissolution by magnetic resonance electric current density imaging.
    Mikac U; Demsar A; Demsar F; Sersa I
    J Magn Reson; 2007 Mar; 185(1):103-9. PubMed ID: 17188009
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Porous hydroxyapatite tablets as carriers for low-dosed drugs.
    Cosijns A; Vervaet C; Luyten J; Mullens S; Siepmann F; Van Hoorebeke L; Masschaele B; Cnudde V; Remon JP
    Eur J Pharm Biopharm; 2007 Sep; 67(2):498-506. PubMed ID: 17407810
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Quantitative measurements of localized density variations in cylindrical tablets using X-ray microtomography.
    Busignies V; Leclerc B; Porion P; Evesque P; Couarraze G; Tchoreloff P
    Eur J Pharm Biopharm; 2006 Aug; 64(1):38-50. PubMed ID: 16621489
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Preparation of monolithic osmotic pump system by coating the indented core tablet.
    Liu L; Che B
    Eur J Pharm Biopharm; 2006 Oct; 64(2):180-4. PubMed ID: 16797951
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High-amylose sodium carboxymethyl starch matrices for oral, sustained drug-release: formulation aspects and in vitro drug-release evaluation.
    Brouillet F; Bataille B; Cartilier L
    Int J Pharm; 2008 May; 356(1-2):52-60. PubMed ID: 18280069
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Membrane formation and drug loading effects in high amylose starch tablets studied by NMR imaging.
    Thérien-Aubin H; Zhu XX; Ravenelle F; Marchessault RH
    Biomacromolecules; 2008 Apr; 9(4):1248-54. PubMed ID: 18357992
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Modeling drug release from PVAc/PVP matrix tablets.
    Siepmann F; Eckart K; Maschke A; Kolter K; Siepmann J
    J Control Release; 2010 Jan; 141(2):216-22. PubMed ID: 19737588
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Citric acid monohydrate as a release-modifying agent in melt extruded matrix tablets.
    Schilling SU; Bruce CD; Shah NH; Malick AW; McGinity JW
    Int J Pharm; 2008 Sep; 361(1-2):158-68. PubMed ID: 18582547
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Influence of processing parameters and formulation factors on the drug release from tablets powder-coated with Eudragit L 100-55.
    Sauer D; Zheng W; Coots LB; McGinity JW
    Eur J Pharm Biopharm; 2007 Sep; 67(2):464-75. PubMed ID: 17451929
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High-amylose carboxymethyl starch matrices for oral sustained drug-release: in vitro and in vivo evaluation.
    Nabais T; Brouillet F; Kyriacos S; Mroueh M; Amores da Silva P; Bataille B; Chebli C; Cartilier L
    Eur J Pharm Biopharm; 2007 Mar; 65(3):371-8. PubMed ID: 17275270
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development of a method for the determination of caffeine anhydrate in various designed intact tablets [correction of tables] by near-infrared spectroscopy: a comparison between reflectance and transmittance technique.
    Ito M; Suzuki T; Yada S; Kusai A; Nakagami H; Yonemochi E; Terada K
    J Pharm Biomed Anal; 2008 Aug; 47(4-5):819-27. PubMed ID: 18508223
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dissolution characteristics of cylindrical particles and tablets.
    Fukunaka T; Yaegashi Y; Nunoko T; Ito R; Golman B; Shinohara K
    Int J Pharm; 2006 Mar; 310(1-2):146-53. PubMed ID: 16414218
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A comparative study of dissolution characteristics of polymeric and wax granulations of theophylline and their tablets.
    Uhumwangho MU; Okor RS
    Pak J Pharm Sci; 2008 Jul; 21(3):230-6. PubMed ID: 18614417
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Assessment of Albizia zygia gum as a binding agent in tablet formulations.
    Odeku OA
    Acta Pharm; 2005 Sep; 55(3):263-76. PubMed ID: 16375837
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.